The 'gut punch' of cancer drug shortages; Why some cancer cells resist treatment

Cancer patients are struggling with the uncertainty of whether drug shortages will impact their odds of survival.

July 21, 2023 Check out STAT+

Sponsored By

Hannah Yoon for STAT Cancer drug shortages deliver 'gut punch' to patients unsure if their survival odds will be undercut Mairéad McInerney says she'll never know whether cancer drug shortages affected her odds of beating breast cancer. By Charlotte Huff STAT+ | A new explanation for why some stubborn cancer cells resist treatment Among the vast population of cancer cells in a tumor, some have random mutations that help these cells survive an onslaught of drugs. By Angus Chen STAT+ | Hospitals struggle to make money on CAR-T cancer therapies, but their fortunes may change Medicare pays so little for pricey CAR-T cancer drugs that hospitals sometimes lose money providing them. But that could soon change. By John Wilkerson Adobe STAT+ | European regulatory panel weighs against approval of Mirati's KRAS-targeted lung cancer drug Mirati Therapeutics said it would appeal European regulators' negative review of its lung cancer drug Krazati. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser